EUVIMEDEUVIMED entdecken
Kohortenstudie

Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study

Abdul Rasheed Bahar, Yasemin Bahar, Hewad Hewadmal, Shaheena Z Raheem, Thomas Crawford

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.7745 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Abdul Rasheed Bahar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is a major contributor to atrial fibrillation (AF) recurrence following catheter ablation. Tirzepatide has demonstrated superior weight reduction and cardiometabolic benefits compared with traditional glucagon-like peptide-1 receptor agonists (GLP-1RAs), but its impact on post-ablation outcomes remains uncertain. We compared clinical outcomes among patients treated with tirzepatide versus GLP-1RAs following AF ablation.

Methods

We conducted a retrospective cohort study using the TriNetX Global Research Network. Adult patients with AF who underwent catheter ablation and subsequently received either tirzepatide or a GLP-1RA were identified. After 1:1 propensity score matching, 1,661 patients remained in each cohort. The primary outcome was AF recurrence. Secondary outcomes included progression to permanent AF, repeat AF ablation, all-cause mortality, ischemic stroke, heart failure hospitalization, cardioversion, atrioventricular nodal ablation, and amiodarone use. Risk ratios (RRs) with 95% confidence intervals (CIs) were calculated.

Results

Compared with GLP-1RAs, tirzepatide was associated with a significantly lower risk of AF recurrence (35.8% vs 42.4%; RR 0.85, 95% CI 0.78-0.92; p

Zitieren

APA

Bahar, A. R., Bahar, Y., Hewadmal, H., Raheem, S. Z., & Crawford, T. (2026). Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7745

Vancouver

Bahar AR, Bahar Y, Hewadmal H, Raheem SZ, Crawford T. Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7745

BibTeX
@article{Bahar2026,
  author = {Bahar, Abdul Rasheed and Bahar, Yasemin and Hewadmal, Hewad and Raheem, Shaheena Z and Crawford, Thomas},
  title = {Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.7745}
}
Kostenlos starten →